ADIAL PHARMACEUTICALS, INC. — Investor Relations & Filings
Filings indexed
519
across all filing types
Latest filing
2026-03-03
Regulatory Filings
Country
US
United States of America
Listing
US
ADIL
Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development of therapies for the treatment and prevention of addiction and related disorders. The company's lead investigational drug candidate is AD04, a genetically targeted, serotonin-3 receptor antagonist for the treatment of Alcohol Use Disorder (AUD). AD04 is being developed in conjunction with a proprietary companion diagnostic genetic test. This test is designed to identify patients with specific genotypes who are most likely to respond to the treatment, representing a personalized medicine approach to managing addiction.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - ADIAL PHARMACEUTICALS, INC. (0001513525) (Filer) | 2026-03-03 | English | |
| 8-K - ADIAL PHARMACEUTICALS, INC. (0001513525) (Filer) | 2026-02-24 | English | |
| 8-K - ADIAL PHARMACEUTICALS, INC. (0001513525) (Filer) | 2026-02-04 | English | |
| CURRENT REPORT | 2026-01-06 | English | |
| DEFINITIVE PROXY STATEMENT | 2026-01-06 | English | |
| PRELIMINARY PROXY STATEMENT | 2025-12-23 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
5 filings
| |||||
| 32892978 | 8-K - ADIAL PHARMACEUTICALS, INC. (0001513525) (Filer) | 2026-03-03 | English | ||
| 32892980 | 8-K - ADIAL PHARMACEUTICALS, INC. (0001513525) (Filer) | 2026-02-24 | English | ||
| 32892979 | 8-K - ADIAL PHARMACEUTICALS, INC. (0001513525) (Filer) | 2026-02-04 | English | ||
| 12425774 | CURRENT REPORT | 2026-01-06 | English | ||
| 12425775 | DEFINITIVE PROXY STATEMENT | 2026-01-06 | English | ||
|
2025
10 filings
| |||||
| 12425776 | PRELIMINARY PROXY STATEMENT | 2025-12-23 | English | ||
| 12425777 | PROSPECTUS SUPPLEMENT | 2025-12-19 | English | ||
| 12425778 | Regulatory Filings 2025 | 2025-12-18 | English | ||
| 12425779 | REGISTRATION STATEMENT | 2025-12-12 | English | ||
| 12425780 | Regulatory Filings 2025 | 2025-12-03 | English | ||
| 12425781 | CURRENT REPORT | 2025-12-01 | English | ||
| 12425782 | CURRENT REPORT | 2025-11-14 | English | ||
| 12425783 | QUARTERLY REPORT | 2025-11-13 | English | ||
| 12425784 | CURRENT REPORT | 2025-09-16 | English | ||
| 12425785 | REGISTRATION STATEMENT | 2025-09-09 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
ADIAL PHARMACEUTICALS, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35331/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35331 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35331 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35331 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35331}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ADIAL PHARMACEUTICALS, INC. (id: 35331)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.